✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Genmab A/S

Common Name
Genmab
Country
Denmark
Sector
Healthcare
Industry
Biotechnology
Employees
2,681
Ticker
GMAB
Exchange
NASDAQ COPENHAGEN A/S
Description
Genmab A/S is an international biotechnology company focused on the research, development, and commercialization of innovative antibody-based therapies. Its primary mission is to transform the treatme...

Genmab's Climate Target Data Preview

As of 2024, Genmab has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Genmab's climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy/Paste is a PRO feature.
a
2030
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
0000000
2050
Limited Data Preview
You are viewing a limited preview of Genmab’s Climate Target dataset. The full dataset, available for download, includes detailed baseline information for both absolute and intensity targets, along with reported progress and achievement details as of 2024.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Genmab’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Genmab’s data sources below and access millions more through our Disclosure Search.

a. Genmab's Annual Report 2024

Insights into Genmab's Greenhouse Gas Emissions Pathways

As of 2024, Genmab has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.a

Does Genmab have a target to reduce the emissions from its operations?

As of 2024, Genmab has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a

Genmab's most ambitious operational target is to reduce these emissions by 90% by 2050, compared to a baseline of 1,697 Metric Tonnes of CO2 equivalent (mtCO2e) in 2024.a

a

Genmab's Operational (Scope 1+2) Emissions Pathway

20242030205004509001.35 k1.8 kBaselineTarget 2030 (-42%)Target 2050 (-90%)
Want Full Access to Genmab's Climate Targets Dataset?
Start 30-Day Free Trial